Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Timber Pharmaceuticals (TMBRQ)
OTHER OTC:TMBRQ
Timber Pharmaceuticals (TMBRQ) Stock Price & Analysis
796 Followers
TMBRQ Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range<$0.01 - $3.36
Previous Close$0.01
Volume20.05K
Average Volume (3M)N/A
Market Cap
$343.00
Enterprise Value-$4.55M
Total Cash (Recent Filing)$5.18M
Total Debt (Recent Filing)$625.43K
Price to Earnings (P/E)>-0.1
Beta-0.96
Next Earnings
May 08, 2024EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-5.38
Shares Outstanding3,086,489
10 Day Avg. Volume3,529
30 Day Avg. VolumeN/A
Standard Deviation0.35
R-Squared0.02
Alpha-0.09
Financial Highlights & Ratios
Price to Book (P/B)0.00
Price to Sales (P/S)0.00100
Price to Cash Flow (P/CF)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue-24.08
Enterprise Value/Gross Profit-11.30
Enterprise Value/Ebitda0.23
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Timber Pharmaceuticals News
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
TMBRQ FAQ
What was Timber Pharmaceuticals’s price range in the past 12 months?
Timber Pharmaceuticals lowest stock price was <$0.01 and its highest was $3.36 in the past 12 months.
What is Timber Pharmaceuticals’s market cap?
Currently, no data Available
When is Timber Pharmaceuticals’s upcoming earnings report date?
Timber Pharmaceuticals’s upcoming earnings report date is May 08, 2024 which is in 8 days.
How were Timber Pharmaceuticals’s earnings last quarter?
Currently, no data Available
Is Timber Pharmaceuticals overvalued?
According to Wall Street analysts Timber Pharmaceuticals’s price is currently Overvalued.
Does Timber Pharmaceuticals pay dividends?
Timber Pharmaceuticals does not currently pay dividends.
What is Timber Pharmaceuticals’s EPS estimate?
Timber Pharmaceuticals’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Timber Pharmaceuticals have?
Timber Pharmaceuticals has 3,432,735 shares outstanding.
What happened to Timber Pharmaceuticals’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Timber Pharmaceuticals?
Currently, no hedge funds are holding shares in TMBRQ
---
Company Description
Timber Pharmaceuticals
BioPharmX Corp. engages in the provision of healthcare products through platform technologies for pharmaceutical, over-the-counter, and supplement applications in dermatology. Its platforms include Topical Gel, Injectable, and Encapsulation. The company was founded by James R. Pekarsky and Anja B. Krammer on August 30, 2010 and is headquartered in Menlo Park, CA.
---
TMBRQ Stock 12 Months Forecast
Average Price Target
―---